Mahindra Manulife Multi Cap Fund - Direct Plan -Growth
Mahindra Manulife Investment Management Private Limited · Direct Plan · Growth
Fund overview
1% on or before 3M, Nil after 3M
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,169 | +169 |
| 3 Years | ₹1,000 | ₹1,597 | +597 |
| 5 Years | ₹1,000 | ₹2,182 | +1,182 |
Calculated using the fund's annualised return since inception (16.9% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
74 securitiesTop 10 holdings make up 31.5% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Triparty Repo | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 5.83% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 5.01% |
| Multi Commodity Exchange of India Ltd | Capital Markets | Mid Cap | 4.21% |
| ICICI Bank Ltd | Banks | Large Cap | 3.26% |
| HDFC Bank Ltd | Banks | Large Cap | 2.85% |
| Adani Enterprises Ltd | Metals & Minerals Trading | Large Cap | 2.79% |
| Neuland Laboratories Ltd | Pharmaceuticals & Biotechnology | Small Cap | 2.73% |
| Oil India Ltd | Oil & Gas | Mid Cap | 2.47% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 2.35% |
| APL Apollo Tubes Ltd | Industrial Products | Mid Cap | 2.16% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹7,457 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹6,967 Cr
Exit load, stamp duty & tax
11-May-17
1% on or before 3M, Nil after 3M
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 11.26% |
| Beta | 0.84 |
| Sharpe Ratio | 4.00 |
| Sortino Ratio | 0.31 |
| Treynor Ratio | 0.54 |
| Jensen's Alpha | 12.17 |
| Information Ratio | 0.33 |
| R-Squared | 77.61% |
| Max Drawdown | -2.64% |
| Upside Capture | 110.42% |
| Downside Capture | 44.95% |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Provide Medium To Long Term Capital Appreciation Through Appropriate Diversification And Taking Low Risk On Business Quality. The Diversified Portfolio Would Predominantly Consist Of Equity And Equity Related Securities Including Derivatives. However, There Can Be No Assurance That The Investment Objective Of The Scheme Will Be Achieved.
Fund house
Mahindra Manulife Investment Management Private Limited
Frequently asked questions
What is the NAV of Mahindra Manulife Multi Cap Fund - Direct Plan -Growth?
The NAV of Mahindra Manulife Multi Cap Fund - Direct Plan -Growth is ₹43.71 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Mahindra Manulife Multi Cap Fund - Direct Plan -Growth?
The expense ratio charged by Mahindra Manulife Multi Cap Fund - Direct Plan -Growth is 0.93%.
What is the Min. SIP of Mahindra Manulife Multi Cap Fund - Direct Plan -Growth?
The minimum SIP investment in Mahindra Manulife Multi Cap Fund - Direct Plan -Growth is ₹500 per month.
What is the Min. Lumpsum of Mahindra Manulife Multi Cap Fund - Direct Plan -Growth?
The minimum lumpsum investment in Mahindra Manulife Multi Cap Fund - Direct Plan -Growth is ₹1,000.
What is the Exit Load of Mahindra Manulife Multi Cap Fund - Direct Plan -Growth?
The exit load for Mahindra Manulife Multi Cap Fund - Direct Plan -Growth is: 1% on or before 3M, Nil after 3M
.svg){kind=small}